Regeneron Pharmaceuticals Inc - REGN - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 19, 2013

Regeneron Pharmaceuticals Inc - SIC # 8731

Ticker	Exchange	SIC #	Website	Latest Ticker
REGN	Nasdaq	8731	http://www.regeneron.com/	250.31 -4.56
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for Regeneron Pharmaceuticals Inc Today’s 3 Worst Stocks - May 23rd, 2013 5:06 pm Regeneron Pharmaceuticals Inc. (REGN): Today's Featured Drugs Laggard - May 23rd, 2013 3:01 pm Agree To Buy Regeneron Pharmaceuticals At $165, Earn 9.8% - May 23rd, 2013 12:04 pm Amgen Stock Checkup for May - May 23rd, 2013 12:04 pm Applied Materials CEO Sells 300K Shares and 4 Insider Sales to Note - May 23rd, 2013 7:01 am Is This Momentum Stock’s Rally Over? - May 22nd, 2013 3:22 pm Sanofi/REGN's Dupilumab Data Published - May 22nd, 2013 2:00 pm Regeneron Shareholders Watching Optina Trial Closely - May 22nd, 2013 1:56 pm Regeneron moves higher on asthma drug study data - May 22nd, 2013 1:20 pm Regeneron moves higher on asthma drug study data - May 22nd, 2013 1:20 pm Stocks Stage Broad Advance; Bristol-Myers Leads Medicals - May 22nd, 2013 10:09 am Regeneron and Sanofi: An Unstoppable Biotech Duo? - May 21st, 2013 4:32 pm Regeneron, Sanofi asthma drug seen as potential game changer - May 21st, 2013 2:27 pm New Drug May Help Some Asthmatics, Study Finds - May 21st, 2013 2:12 pm New Asthma Drug Generates Excitement For Patients -- And Its Maker - May 21st, 2013 6:52 am Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine - May 21st, 2013 6:15 am Regeneron settles all pending litigation with Roche's Genentech - May 20th, 2013 4:26 pm Regeneron Pharmaceuticals, Inc. Presents at UBS Global Healthcare Conference, May-20-2013 10:00 AM - May 20th, 2013 11:50 am 5 Stocks Underperforming Today In The Drugs Industry - May 20th, 2013 11:04 am REGENERON PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement - May 20th, 2013 8:07 am View All Current Headlines >>